Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in TD Cowen's 45th Annual Health Care Conference. Company...
Thursday, February 20, 2025 2 min read
Key Takeaway: Jazz Pharmaceuticals plc has announced its participation in TD Cowen's 45th Annual Health Care Conference, where company management will engage in a fireside chat. This event is scheduled for March 5, 2025, and will be accessible via an audio webcast on their investor relations website. The company's commitment to innovation in life-changing medicines will be highlighted during this event, showcasing their work in various therapeutic areas including oncology and neuroscience.
Market Sentiment Analysis
POSITIVE FACTORS
Jazz Pharmaceuticals will participate in a major healthcare conference, indicating their active involvement in the industry.
Management's fireside chat could provide valuable insights into the company's future strategies and developments.
The archived webcasts ensure transparency and accessibility for investors.
Full Press Release Details
DUBLIN , Feb. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the Company will participate in TD Cowen's 45 th Annual Health Care Conference. Company management will participate in a fireside chat on Wednesday, March 5, 2025 , at 7:30 a.m. PT / 10:30 a.m. ET / 3:30 p.m. GMT .
An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations . A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Investors: Jeff Macdonald Executive Director, Investor Relations Jazz Pharmaceuticals plc [email protected] Ireland +353 1 634 3211 U.S. +1 650 496 2717
Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc [email protected] Ireland +353 1 637 2141 U.S. +1 215 867 4948
SOURCE Jazz Pharmaceuticals plc
21 %
Frequently Asked Questions
When is the TD Cowen Health Care Conference?
The conference is on March 5, 2025, at 7:30 a.m. PT.
Where can I watch the Jazz Pharmaceuticals fireside chat?
The fireside chat will be available on the Jazz Pharmaceuticals website.
How long will the audio webcast replay be available?
The replay of the webcast will be archived for 30 days.
What is Jazz Pharmaceuticals focused on?
Jazz Pharmaceuticals focuses on developing life-changing medicines for serious diseases.
Where is Jazz Pharmaceuticals headquartered?
Jazz Pharmaceuticals is headquartered in Dublin, Ireland.